Early Experience after Developing a Pathology Laboratory in Malawi, with Emphasis on Cancer Diagnoses

Abstract

BackgroundDespite increasing cancer burden in Malawi, pathology services are limited. We describe operations during the first 20 months of a new pathology laboratory in Lilongwe, with emphasis on cancer diagnoses.Methods and FindingsWe performed a cross-sectional study of specimens from the Kamuzu Central Hospital pathology laboratory between July 1, 2011 and February 28, 2013. Patient and specimen characteristics, and final diagnoses are summarized. Diagnoses were categorized as malignant, premalignant, infectious, other pathology, normal or benign, or nondiagnostic. Patient characteristics associated with premalignancy and malignancy were assessed using logistic regression. Of 2772 specimens, 2758 (99%) with a recorded final diagnosis were included, drawn from 2639 unique patients. Mean age was 38 years and 63% were female. Of those with documented HIV status, 51% had unknown status, and 36% with known status were infected. Histologic specimens comprised 91% of cases, and cytologic specimens 9%. Malignant diagnoses were most common overall (n = 861, 31%). Among cancers, cervical cancer was most common (n = 117, 14%), followed by lymphoma (n = 91, 11%), esophageal cancer (n = 86, 10%), sarcoma excluding Kaposi sarcoma (n = 75, 9%), and breast cancer (n = 61, 7%). HIV status was known for 95 (11%) of malignancies, with HIV prevalence ranging from 9% for breast cancer to 81% for cervical cancer. Increasing age was consistently associated with malignancy [bivariable odds ratio 1.24 per decade increase (95% CI 1.19–1.29) among 2685 patients with known age; multivariable odds ratio 1.33 per decade increase (95% CI 1.14–1.56) among 317 patients with known age, gender, and HIV status], while HIV infection and gender were not.ConclusionsDespite selection and referral bias inherent in these data, a new pathology laboratory in Lilongwe has created a robust platform for cancer care and research. Strategies to effectively capture clinical information for pathologically confirmed cancers can allow these data to complement population-based registration.

Quantifying bias in survival estimates resulting from loss to follow‐up among children with lymphoma in Malawi

“…Of these, 100 (83%) had Burkitt lymphoma (BL) and 21 (27%) Hodgkin lymphoma (HL), the two commonest pediatric lymphoma subtypes in SSA. However, we acknowledge that less frequent non‐Hodgkin lymphoma subtypes might be diagnosed locally as BL given limited immunohistochemistry and absent molecular diagnostic tools, despite major efforts by our group to improve diagnostic pathology in Lilongwe . Baseline characteristics are shown in Table .…”

A framework for improving early detection of breast cancer in sub-Saharan Africa: A qualitative study of help-seeking behaviors among Malawian women

“…The public health system provides free basic services through local health centers, small district hospitals, and referral tertiary care hospitals. Cancer is an increasingly important problem for the resource-limited health system [16–18]. …”

Plasma Epstein-Barr virus DNA for pediatric Burkitt lymphoma diagnosis, prognosis and response assessment in Malawi

“…All enrolled cases were confirmed using a novel weekly telepathology consultative platform involving 2–4 pathologists in Malawi and the United States who rendered a consensus opinion, after review of cytology slides or hematoxylin and eosin stained tissue sections. This model has been described in detail previously and demonstrated excellent concordance with subsequent United States review . Manual IHC for biopsy specimens or centrifuged cell blocks was performed locally, including CD3, CD20, CD30, CD45, CD138, Ki‐67, BCL2, and terminal deoxynucleotidyl transferase (TDT).…”